A benign neoplasm of the right kidney (D30.01) is a non-malignant tumor originating from the parenchymal or mesenchymal tissues of the kidney. While these growths do not possess the metastatic potential of malignant lesions like renal cell carcinoma, they can still cause significant morbidity through local growth, compression of the renal collecting system, or spontaneous hemorrhage. The most clinically significant types include renal oncocytomas, which can be radiographically indistinguishable from malignant tumors, and renal angiomyolipomas (AMLs), which are composed of vascular, smooth muscle, and adipose tissue. Angiomyolipomas are particularly noteworthy for their risk of spontaneous retroperitoneal rupture (Wunderlich syndrome) once they exceed 4 cm in diameter. Many of these neoplasms are discovered incidentally during abdominal imaging (incidentalomas) and may require ongoing surveillance or surgical intervention depending on size, growth rate, and the presence of clinical symptoms.
Specify the exact histological type when known from biopsy or imaging characteristics to differentiate from uncertain behavior codes.
Example: Patient presents for follow-up of a 3.5 cm right renal mass. CT imaging remains consistent with a right-sided renal angiomyolipoma without evidence of hemorrhage. Documentation supports D30.01 for the confirmed benign status of the right kidney neoplasm. Plan is continued active surveillance with annual imaging to monitor for size increases exceeding 4 cm, which may necessitate embolization.
Billing Focus: Confirmation of laterality to the right kidney and the specific benign nature of the lesion to support ICD-10-CM code D30.01.
Document the absence of symptoms or the presence of specific manifestations such as hematuria or flank pain to justify diagnostic procedures.
Example: A 52-year-old female with an incidental finding of a right renal oncocytoma during workup for vague abdominal discomfort. Patient denies gross hematuria or acute right flank pain. Examination of the right costovertebral angle is non-tender. Documentation of the benign neoplasm of the right kidney supports medical necessity for the initial renal ultrasound and subsequent CT urogram.
Billing Focus: Symptom documentation justifies the medical necessity of imaging and high-level evaluation and management services.
Integrate findings from pathology reports specifically naming benign entities like oncocytoma or metanephric adenoma.
Example: Post-operative note for right partial nephrectomy. Pathology confirms a 2.8 cm right renal oncocytoma with negative margins, confirming the diagnosis of a benign neoplasm of the right kidney. No malignant cells identified. The patient is recovering well with stable creatinine levels. Final diagnosis updated from uncertain behavior to D30.01.
Billing Focus: Updates the diagnosis from a working code (like D41.01) to a definitive code (D30.01) based on surgical pathology.
Include measurements and growth rates for lesions to support the transition from observation to active intervention.
Example: Right renal angiomyolipoma has grown from 2.1 cm to 4.2 cm over the last 18 months. Due to the increased risk of spontaneous hemorrhage associated with lesions over 4 cm, we will proceed with elective angioembolization. Patient is aware that although this is a benign neoplasm of the right kidney, the size poses a risk of retroperitoneal bleed.
Billing Focus: Size documentation provides the clinical rationale for procedure-based CPT codes like 37242.
Clearly link the diagnosis to any underlying genetic syndromes such as Tuberous Sclerosis Complex.
Example: Patient with known Tuberous Sclerosis Complex (TSC) presents for evaluation of multiple right-sided renal angiomyolipomas. Largest lesion in the right lower pole measures 3.0 cm. These are documented as benign neoplasms of the right kidney secondary to TSC. Monitoring renal function closely as multiple lesions increase the risk of parenchymal loss.
Billing Focus: Coding both the benign neoplasm (D30.01) and the manifestation (Q85.1) provides a complete diagnostic picture for billing.
Used for routine monitoring of an established patient with a known benign lesion requiring low-level clinical oversight.
Appropriate when the physician must analyze new imaging findings and discuss surgical vs. conservative options for a benign neoplasm.
The standard of care for removing large or symptomatic benign masses while preserving renal function.
Essential for characterizing the mass, determining fat content, and monitoring growth.
Performed when imaging is inconclusive to confirm the benign nature (e.g., D30.01) versus malignancy.
Common treatment for renal angiomyolipomas to prevent spontaneous rupture and bleeding.
Cost-effective screening and serial monitoring tool for benign renal lesions.
Used to confirm genetic syndromes associated with multiple benign renal neoplasms.
Reserved for very large benign masses that have replaced the majority of the renal parenchyma.
Standard for new referrals where the physician must perform a comprehensive review of outside imaging and history.